Published in Acta Neuropathol on December 15, 2011
The pathobiology of vascular dementia. Neuron (2013) 3.07
Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci (2013) 1.92
The heart-brain connection: mechanistic insights and models. Neth Heart J (2013) 1.56
Heart failure and Alzheimer's disease. J Intern Med (2014) 1.54
Amyloid burden and sleep blood pressure in amnestic mild cognitive impairment. Neurology (2015) 1.41
Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci (2013) 1.27
Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol (2013) 1.15
Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition. J Cereb Blood Flow Metab (2013) 1.06
Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain. Exp Gerontol (2012) 1.01
The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis. Biochim Biophys Acta (2015) 0.99
The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease. Neuropathol Appl Neurobiol (2013) 0.98
The pericyte: a forgotten cell type with important implications for Alzheimer's disease? Brain Pathol (2014) 0.96
Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab (2013) 0.95
The ins and outs of the BCCAo model for chronic hypoperfusion: a multimodal and longitudinal MRI approach. PLoS One (2013) 0.92
Retinal microvascular network attenuation in Alzheimer's disease. Alzheimers Dement (Amst) (2015) 0.90
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. Front Aging Neurosci (2014) 0.89
Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab (2016) 0.89
Chronic cerebral hypoperfusion induces vascular plasticity and hemodynamics but also neuronal degeneration and cognitive impairment. J Cereb Blood Flow Metab (2015) 0.88
Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases. Cell Mol Neurobiol (2016) 0.88
Dementia in the oldest old. Nat Rev Neurol (2013) 0.86
From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration. Cell Mol Neurobiol (2014) 0.86
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease. Acta Neuropathol (2016) 0.85
Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation. Acta Neuropathol Commun (2013) 0.84
Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease. Front Aging Neurosci (2015) 0.84
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol (2016) 0.83
Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain (2015) 0.83
Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol (2016) 0.82
Cerebral hemodynamics of the aging brain: risk of Alzheimer disease and benefit of aerobic exercise. Front Physiol (2014) 0.82
Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain. Brain Pathol (2014) 0.82
Phosphodiesterase III inhibitor promotes drainage of cerebrovascular β-amyloid. Ann Clin Transl Neurol (2014) 0.82
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci (2017) 0.82
Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy. Acta Neuropathol (2016) 0.79
Genes influence the amplitude and timing of brain hemodynamic responses. Neuroimage (2015) 0.79
Microinfarcts are common and strongly related to dementia in the oldest-old: The 90+ study. Alzheimers Dement (2016) 0.79
Cerebral/Peripheral Vascular Reactivity and Neurocognition in Middle-Age Athletes. Med Sci Sports Exerc (2015) 0.78
Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling. Mol Brain (2016) 0.78
Amyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis). Front Aging Neurosci (2014) 0.78
Severe chronic cerebral hypoperfusion induces microglial dysfunction leading to memory loss in APPswe/PS1 mice. Oncotarget (2016) 0.78
Vascular Contributions to Cognitive Impairment and Dementia: Topical Review of Animal Models. Stroke (2016) 0.77
Rodent Models of Vascular Cognitive Impairment. Transl Stroke Res (2016) 0.77
Cerebral vascular amyloid seeds drive amyloid β-protein fibril assembly with a distinct anti-parallel structure. Nat Commun (2016) 0.76
The effects of transcranial LED therapy (TCLT) on cerebral blood flow in the elderly women. Lasers Med Sci (2014) 0.76
Mild cognitive impairment: vascular risk factors in community elderly in four cities of Hebei Province, China. PLoS One (2015) 0.76
Translational models for vascular cognitive impairment: a review including larger species. BMC Med (2017) 0.75
Investigation of redox status in chronic cerebral hypoperfusion-induced neurodegeneration in rats. Appl Transl Genom (2015) 0.75
A murine model of inflammation-induced cerebral microbleeds. J Neuroinflammation (2016) 0.75
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy. Acta Neuropathol Commun (2017) 0.75
Vascular function, cerebral cortical thickness, and cognitive performance in middle-aged Hispanic and non-Hispanic Caucasian adults. J Clin Hypertens (Greenwich) (2015) 0.75
Comparative Analysis of Cortical Microinfarcts and Microbleeds using 3.0-Tesla Postmortem Magnetic Resonance Images and Histopathology. J Alzheimers Dis (2017) 0.75
Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity. Cell Death Dis (2017) 0.75
Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases. Neurochem Res (2017) 0.75
Dl-3-n-Butylphthalide Treatment Enhances Hemodynamics and Ameliorates Memory Deficits in Rats with Chronic Cerebral Hypoperfusion. Front Aging Neurosci (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (2006) 8.15
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med (2001) 3.84
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol (1986) 3.09
A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol (1986) 3.04
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol (2008) 2.59
Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem (2004) 2.45
Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) J Neuropathol Exp Neurol (1994) 2.34
Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain (2008) 2.34
White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke (2004) 2.29
Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology (2006) 2.06
Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol (1998) 1.92
Beta-amyloid, blood vessels, and brain function. Stroke (2009) 1.89
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Vascular pathology in the aged human brain. Acta Neuropathol (2010) 1.78
Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke (2004) 1.74
Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol (2009) 1.74
Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. Am J Pathol (2006) 1.73
Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Med (2009) 1.72
Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy. Brain Pathol (2009) 1.69
Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke (2002) 1.66
Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci (2004) 1.63
Clinical diagnosis of Binswanger's disease. J Neurol Neurosurg Psychiatry (1990) 1.63
Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol (2008) 1.60
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol (1996) 1.54
Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther (1996) 1.53
AD brain pathology: vascular origins? Results from the HAAS autopsy study. Neurobiol Aging (2007) 1.39
Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol (2011) 1.37
Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke (2007) 1.34
White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated. J Neurosci (2007) 1.32
Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol (2010) 1.31
Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke (2006) 1.26
Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry (2006) 1.25
Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. Acta Neuropathol (1998) 1.22
Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol (1995) 1.22
Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res (2009) 1.13
Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia. Neuroreport (2009) 1.11
A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke (2010) 1.11
Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia. Dement Geriatr Cogn Disord (2004) 0.98
Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors. Neurobiol Dis (2006) 0.91
The influence of chronic cerebral hypoperfusion on cognitive function and amyloid β metabolism in APP overexpressing mice. PLoS One (2011) 0.89
Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy. Ann Neurol (2002) 0.82
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci (2008) 5.89
Mutations of optineurin in amyotrophic lateral sclerosis. Nature (2010) 4.54
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci (2005) 3.69
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J (2008) 3.51
White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke (2006) 3.27
Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med (2012) 2.80
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci U S A (2005) 2.58
CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell (2002) 2.53
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell (2013) 2.32
White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke (2004) 2.29
Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. J Neuropathol Exp Neurol (2013) 2.12
Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron (2003) 2.12
Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity. Neuron (2007) 2.08
Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet (2012) 2.01
Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun (2003) 1.96
Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J Neurosci (2010) 1.91
Rac-GAP alpha-chimerin regulates motor-circuit formation as a key mediator of EphrinB3/EphA4 forward signaling. Cell (2007) 1.82
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.78
Spontaneous remission of a massive CNS inflammation with eosinophilic infiltrate. Intern Med (2003) 1.73
In vivo evidence of CHIP up-regulation attenuating tau aggregation. J Neurochem (2005) 1.66
Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J Neurochem (2002) 1.57
Does vascular pathology contribute to Alzheimer changes? J Neurol Sci (2012) 1.52
CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J Neurochem (2004) 1.50
Deletion of Atf6α impairs astroglial activation and enhances neuronal death following brain ischemia in mice. J Neurochem (2015) 1.48
Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model. Neurobiol Aging (2013) 1.46
CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol (2002) 1.43
Hypersomnia caused by isolated angiitis of the CNS. Intern Med (2005) 1.42
Bereitschaftspotential augmentation by neuro-feedback training in Parkinson's disease. Clin Neurophysiol (2013) 1.41
The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila. PLoS Genet (2010) 1.41
[A case of status epilepticus with a possible therapeutic effect by dantrolene sodium]. Rinsho Shinkeigaku (2011) 1.40
Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke (2007) 1.34
Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol (2010) 1.31
Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke (2009) 1.30
Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem (2002) 1.29
Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid Redox Signal (2007) 1.28
Efficient targeted mutagenesis in medaka using custom-designed transcription activator-like effector nucleases. Genetics (2013) 1.26
A rotarod test for evaluation of motor skill learning. J Neurosci Methods (2010) 1.26
Matrix metalloproteinase-2 plays a critical role in the pathogenesis of white matter lesions after chronic cerebral hypoperfusion in rodents. Stroke (2006) 1.26
SCA8 repeat expansion: large CTA/CTG repeat alleles are more common in ataxic patients, including those with SCA6. Am J Hum Genet (2003) 1.24
Immunohistochemical identification of messenger RNA-related proteins in basophilic inclusions of adult-onset atypical motor neuron disease. Acta Neuropathol (2008) 1.22
Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res (2002) 1.21
Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J Biol Chem (2004) 1.20
Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies. J Biol Chem (2003) 1.19
Direct comparison of histology of microbleeds with postmortem MR images: a case report. Cerebrovasc Dis (2008) 1.18
Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosis. J Biol Chem (2012) 1.15
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders. Ann Neurol (2012) 1.14
L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner. Neurosci Res (2008) 1.13
Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res (2009) 1.13
Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain (2011) 1.13
Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum Mol Genet (2004) 1.12
Pael-R is accumulated in Lewy bodies of Parkinson's disease. Ann Neurol (2004) 1.12
Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiol Aging (2006) 1.11
Early protective effect of bone marrow mononuclear cells against ischemic white matter damage through augmentation of cerebral blood flow. Stroke (2010) 1.11
Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia. Neuroreport (2009) 1.11
A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke (2010) 1.11
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood (2005) 1.10
The endoplasmic reticulum stress sensor, ATF6α, protects against neurotoxin-induced dopaminergic neuronal death. J Biol Chem (2010) 1.09
Septins as diagnostic markers for a subset of human asthenozoospermia. J Urol (2008) 1.09
Nardilysin regulates axonal maturation and myelination in the central and peripheral nervous system. Nat Neurosci (2009) 1.08
Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging (2010) 1.08
Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4. Mol Cell Biol (2005) 1.07
Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice. Stroke (2013) 1.07
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats. Brain (2013) 1.07
Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum Mol Genet (2006) 1.06
Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models. J Neurosci Res (2009) 1.05
Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways. Stroke (2008) 1.05
Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol Aging (2011) 1.05
Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain (2013) 1.05